A world-class team focused on non-invasive refractive vision correction.
"Clerio Vision is developing a revolutionary product for the global refractive surgery market, based on technology licensed from the University of Rochester. The technology has unique applications for next-generation contact lenses as well as intraocular lenses. The company has raised over $15 million in financing from Stonehenge Growth Equity, Armory Square Ventures, prominent angel investors and the National Science Foundation. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered LASIK."
